Solara Active Pharma Sciences (NSE:SOLARA) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences ROE % Adjusted to Book Value?

Solara Active Pharma Sciences's ROE % for the quarter that ended in Dec. 2024 was 2.98%. Solara Active Pharma Sciences's PB Ratio for the quarter that ended in Dec. 2024 was N/A. Solara Active Pharma Sciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was N/A.

Solara Active Pharma Sciences ROE % Adjusted to Book Value Historical Data

The historical data trend for Solara Active Pharma Sciences's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences ROE % Adjusted to Book Value Chart

Solara Active Pharma Sciences Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

10.21

5.26

-2.38

-1.86

-32.60

Solara Active Pharma Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-76.48	-	0.85	-

Competitive Comparison of Solara Active Pharma Sciences's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Solara Active Pharma Sciences's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Solara Active Pharma Sciences ROE % Adjusted to Book Value Calculation

Solara Active Pharma Sciences's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-46.62%	/	1.43
	=	-32.60%

Solara Active Pharma Sciences's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.98%	/	N/A
	=	N/A

Solara Active Pharma Sciences ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Solara Active Pharma Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (NSE:SOLARA) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

SOLARAPP:India 890202:India 541540:India

Address

27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127

Website

https://www.solara.co.in

Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines